TLR7/8 agonist 3
TLR7/8 agonist 3 (Compound II) is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II) ) [1].
Product Specifications
CAS Number
[642473-95-8]
UNSPSC
12352005
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tlr7-8-agonist-3.html
Purity
99.96
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
NC(C)(C)CN1C(COCC)=NC2=C1C3=CC=CC=C3N=C2N
Molecular Formula
C17H23N5O
Molecular Weight
313.40
References & Citations
[1]Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.|[2]Kshirsagar TA, et al., Hydroxyalkyl substituted imidazoquinolines. WO2006098852
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TLR7; TLR8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
